En Carta Diagnostics
Entity

  • En Carta Diagnostics

  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    506

  • Activities

    deeptech healthtech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Paris, France

    Paris

    France

  • Employees

    Scale: 2-10

    Estimated: 6

  • Engaged corporates

    3
    2 2

  • Added in Motherbase

    2 months, 3 weeks ago
Description
  • Value proposition

    Diagnostics for better care, everywhere.

    Diagnostics for Better care, Everywhere.

    En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

    synthetic biology, cell-free, biotech, and molecular sensing

  • Original language

    Diagnostics for better care, everywhere.

    Diagnostics for Better care, Everywhere.

    En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

  • Home | EN CARTA Diagnostics

    En Carta provides low cost and high accuracy paper based diagnostics. Our first product is a SARS-CoV-2 or COVID-19 Diagnostic

    • https://www.encarta.bio/
Corporate interactions BETA
Corporate TypeTweets Articles
Paris Biotech Santé
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations 		Other

18 Jan 2024


50 Partners
50 Partners
Startup accelerator & VC, Venture Capital & Private Equity
50 Partners
Startup accelerator & VC, Venture Capital & Private Equity 		Other

30 Nov 2023


WILCO
WILCO
Software Development
WILCO
Software Development 		Other

31 Jul 2022


Similar entities
Last news
Show all articles
Social network dynamics